Hink Boer

512 total citations
12 papers, 353 citations indexed

About

Hink Boer is a scholar working on Surgery, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Hink Boer has authored 12 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Hink Boer's work include Testicular diseases and treatments (6 papers), Cancer survivorship and care (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Hink Boer is often cited by papers focused on Testicular diseases and treatments (6 papers), Cancer survivorship and care (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Hink Boer collaborates with scholars based in Netherlands, Italy and Norway. Hink Boer's co-authors include Jourik A. Gietema, Roy M. Bremnes, Marianne Brydøy, Hege Sagstuen Haugnes, Sophie D. Fosså, Jan Oldenburg, Alv A. Dahl, George J. Bosl, Coby Meijer and Renske Altena and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Hink Boer

11 papers receiving 349 citations

Peers

Hink Boer
M.G.G. Kier Denmark
Rikke Guldberg Denmark
Carsten Rusner Germany
Cinzia Orazi Italy
Andréa Glezer Brazil
Zuzana Syčová-Milá Slovakia
Dirk Th. Sleyfer Netherlands
Anne I. van Gessel Netherlands
A. Wischnik Germany
Osamu Ichiyanagi Japan
M.G.G. Kier Denmark
Hink Boer
Citations per year, relative to Hink Boer Hink Boer (= 1×) peers M.G.G. Kier

Countries citing papers authored by Hink Boer

Since Specialization
Citations

This map shows the geographic impact of Hink Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hink Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hink Boer more than expected).

Fields of papers citing papers by Hink Boer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hink Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hink Boer. The network helps show where Hink Boer may publish in the future.

Co-authorship network of co-authors of Hink Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Hink Boer. A scholar is included among the top collaborators of Hink Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hink Boer. Hink Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Boer, Hink, Janine Nuver, Joop D. Lefrandt, et al.. (2022). Shared-care survivorship program for testicular cancer patients: safe and feasible. ESMO Open. 7(3). 100488–100488. 3 indexed citations
2.
Boer, Hink, Coby Meijer, Joop D. Lefrandt, et al.. (2020). Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy. The Pharmacogenomics Journal. 21(2). 152–164. 1 indexed citations
3.
Beek, André P. van, Hink Boer, Coby Meijer, et al.. (2019). Insulin‐like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β‐hCG and cancer treatment. Andrology. 7(4). 441–448. 6 indexed citations
4.
Boer, Hink, Janine Nuver, Joop D. Lefrandt, et al.. (2017). Safety and usefulness of patient-centered shared survivorship care after chemotherapy for testicular cancer.. Journal of Clinical Oncology. 35(15_suppl). 4561–4561. 1 indexed citations
5.
Boer, Hink, Renske Altena, Janine Nuver, et al.. (2016). Single-nucleotide polymorphism in the 5-α-reductase gene ( SRD5A2 ) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors. European Journal of Cancer. 54. 104–111. 7 indexed citations
6.
Boer, Hink, Renske Altena, Coby Meijer, et al.. (2016). Vascular fingerprint and vascular damage markers associated with vascular events in testicular cancer patients during and after chemotherapy. European Journal of Cancer. 63. 180–188. 23 indexed citations
7.
Altena, Renske, Rudolf S.N. Fehrmann, Hink Boer, et al.. (2015). Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage. PLoS ONE. 10(1). e0115372–e0115372. 46 indexed citations
8.
Boer, Hink, Johannes H. Proost, Janine Nuver, et al.. (2015). Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors. Annals of Oncology. 26(11). 2305–2310. 58 indexed citations
9.
Boer, Hink, Renske Altena, Coby Meijer, et al.. (2013). Chemotherapy-induced hypercoagulability and biomarkers for prediction of thromboembolic events in patients with metastatic testicular cancer. Journal of Thrombosis and Haemostasis. 11. 94–95.
10.
Nuver, Janine, et al.. (2013). Late gevolgen van kankerbehandeling: gedeelde zorg. Huisarts en Wetenschap. 56(7). 342–345. 1 indexed citations
11.
Haugnes, Hege Sagstuen, George J. Bosl, Hink Boer, et al.. (2012). Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up. Journal of Clinical Oncology. 30(30). 3752–3763. 197 indexed citations
12.
Boer, Hink, Nynke J. Elzenga, W.J. de Boer, & J. J. Meuzelaar. (1999). Pseudoaneurysm of the left ventricle after isolated pericarditis and Staphylococcus aureus septicemia. European Journal of Cardio-Thoracic Surgery. 15(1). 97–99. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.G.G. Kier Breakdown of academic impact, for papers by Rikke Guldberg Breakdown of academic impact, for papers by Carsten Rusner Breakdown of academic impact, for papers by Cinzia Orazi Breakdown of academic impact, for papers by Andréa Glezer Breakdown of academic impact, for papers by Zuzana Syčová-Milá Breakdown of academic impact, for papers by Dirk Th. Sleyfer Breakdown of academic impact, for papers by Anne I. van Gessel Breakdown of academic impact, for papers by A. Wischnik Breakdown of academic impact, for papers by Osamu Ichiyanagi
Rankless by CCL
2026